Australian shares are poised to open modestly lower as Wall Street extended its sell-off, with the S&P 500 now in a correction amid escalating uncertainty about the direction and impact of US tariffs. ASX 200 futures were 0.2 per cent or 12 points lower, predicting the index would extend a… Read More »ASX to slip, Myer in executive clean out; gold at fresh record
At Pacific Private Asset Management, we continue to monitor the performance of our trusted fund partners. The Chester High Conviction Fund (CHCF) has once again demonstrated its resilience and active management strength amidst market volatility. Performance Snapshot – February 2025 The CHCF returned -2.0% for the month of February, outperforming… Read More »Chester High Conviction Fund – February 2025 Monthly Update
Asia-Pacific markets traded mostly higher Monday, as investors parsed Japan’s fourth-quarter economic growth data, while awaiting a slew of central bank decisions from the region this week. Japan’s Nikkei 225 traded around the flatline to close at 39,174.25. while the Topix added 0.28% to close at 2,766.9. South Korea’s Kospi added 0.75% to close… Read More »Tencent shares at highest in over three years; Asia-Pacific markets mostly higher
Stocks rallied on Wednesday, pushing the major averages higher for the second day in a row, as investors looked past the trade turmoil that weighed on the market earlier in the week. The gains came even as notable technology stocks Alphabet and AMD posted steep losses following earnings. The blue-chip… Read More »Dow closes 300 points higher for back-to-back gains as investors look past tariff tumult: Live updates
Points The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of the injection. “FDA has determined that the shortage of tirzepatide injection products, which first began… Read More »FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
Bitcoin’s rally to new heights signals even more momentum for a stock market that’s also at all-time highs, according to Fundstrat’s Tom Lee. “Bitcoin rising is, to me, breaking out of a holding pattern as a precursor to what the S&P 500 is going to do for the rest of the year,” Lee… Read More »Fundstrat’s Tom Lee thinks the bitcoin rally above $100,000 is a bullish signal for stocks